ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0127

Inhibition of Piezo1 Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury by Suppressing Inflammation

Session Information

  • AKI: Mechanisms - 3
    November 08, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Yuan, Xi, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Li, Meng, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Wang, Minghui, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Chen, Wenhao, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Wu, Xinyan, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Xu, Long, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Tang, Chengbin, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Zheng, Qiqi, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Zhang, Hailing, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Wang, Weidong, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China
  • Li, Chunling, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China

Group or Team Name

  • Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University.
Background

Inflammation is a major contributor to acute kidney injury (AKI) induced by ischemia/reperfusion (I/R), the potential mechanism is still unclear. Here we demonstrated that Piezo1, a mechanosensitive cation channel, aggravated I/R-induced AKI and inflammation.

Methods

Bioinformatic analysis was used to screen differentially expressed genes and pathways. Pharmacological inhibition by GsMTx4 and conditional knockout of proximal tubular Piezo1 (Pepck-Cre+/Piezo1fl/fl) were performed in mice to identify the role of Piezo1 in renal I/R. NLRP3 knockout (Nlrp3-/-) mice were used to examine whether Piezo1 mediates NLRP3 inflammasome activation and subsequent inflammation after renal I/R. Primary mouse proximal tubular cells (mPTCs) from Pepck-Cre+/Piezo1fl/fl and Nlrp3-/- mice as well as human HK2 cells were subjected to hypoxia/reoxygenation (H/R) to explore the association between Piezo1 and NLRP3. Virtual screening identified a Piezo1 inhibitor and its renoprotective efficacy was validated.

Results

Piezo1 was highly expressed in renal cortex of I/R mice, which was associated with inflammatory pathways. Inhibition of Piezo1 with GsMTx4 and conditional knockout of proximal tubular Piezo1 markedly ameliorated I/R–induced AKI in mice, accompanied by NLRP3 inflammasome inhibition and decreased production of inflammatory factor IL-1β. NLRP3 knockout ameliorated I/R or Yoda1-induced renal injury and inflammation. In HK2 cells, H/R markedly induced Piezo1 expression and inflammatory responses, which were greatly prevented by GsMTx4 or silence of Piezo1. In mPTCs, H/R or Yoda1 induced Piezo1 activation and inflammatory responses that were markedly prevented by NLRP3 knockout. Mechanistically, inhibition of Piezo1 ameliorates I/R-induced AKI via PI3K/AKT-NLRP3-IL1β pathway, and IL1β promoted the re-activation of Piezo1 via IL1R1-p38-ATF2 signalling or the interaction between IL1R1-Piezo1, forming a pro-inflammatory feedback loop. Baicalin, a flavonoid, was found as a potential inhibitor of Piezo1 by virtual screening and significantly mitigated H/R-induced HK2 cell injury and I/R-induced AKI.

Conclusion

Piezo1 is involved in I/R-induced AKI likely through activating NLRP3 inflammasome, and targeting inhibition of Piezo1 could be a novel therapeutic strategy against I/R-induced AKI.

Digital Object Identifier (DOI)